Evidence map›Paper›PMID 28530513›Full record

Trial reportJournal of medical screening2018

A cluster randomized trial of strategies to increase uptake amongst young women invited for their first cervical screen: The STRATEGIC trial.

H Kitchener, M Gittins, M Cruickshank, C Moseley, S Fletcher, R Albrow, A Gray, L Brabin, D Torgerson, E J Crosbie and 2 more

Abstract readClinical Trial, Phase IIRandomized Controlled Trial
In one paragraph

Trial report in Journal of medical screening, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Non-speculum sampling approaches for cervical screening in older women: randomised controlled trial.The British journal of general practice : the journal of the Royal College of General Practitioners · 2022
    Trial
  11. Trial
  12. Trial
  13. Trial
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

H Kitchener1 Institute of Cancer Sciences, The University of Manchester, St. Mary's Hospital, Manchester, UK.
M Gittins2 Centre for Biostatistics, Institute of Population Health, The University of Manchester, Manchester, UK.
M Cruickshank3 Department of Obstetrics and Gynaecology, Aberdeen Maternity Hospital, Aberdeen, UK.
C Moseley1 Institute of Cancer Sciences, The University of Manchester, St. Mary's Hospital, Manchester, UK.
S Fletcher1 Institute of Cancer Sciences, The University of Manchester, St. Mary's Hospital, Manchester, UK.
R Albrow1 Institute of Cancer Sciences, The University of Manchester, St. Mary's Hospital, Manchester, UK.
A Gray4 Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
L Brabin1 Institute of Cancer Sciences, The University of Manchester, St. Mary's Hospital, Manchester, UK.
D Torgerson5 Department of Health Sciences, University of York, York, UK.
E J Crosbie1 Institute of Cancer Sciences, The University of Manchester, St. Mary's Hospital, Manchester, UK.
A Sargent6 Virology Department, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
C Roberts2 Centre for Biostatistics, Institute of Population Health, The University of Manchester, Manchester, UK.

Funding

Department of Health 09/164/01Department of Health NIHR-CS-012-009
6 · The paper itself

Abstract

Objectives To measure the feasibility and effectiveness of interventions to increase cervical screening uptake amongst young women. Methods A two-phase cluster randomized trial conducted in general practices in the NHS Cervical Screening Programme. In Phase 1, women in practices randomized to intervention due for their first invitation to cervical screening received a pre-invitation leaflet and, separately, access to online booking. In Phase 2, non-attenders at six months were randomized to one of: vaginal self-sample kits sent unrequested or offered; timed appointments; nurse navigator; or the choice between nurse navigator or self-sample kits. Primary outcome was uplift in intervention vs. control practices, at 3 and 12 months post invitation. Results Phase 1 randomized 20,879 women. Neither pre-invitation leaflet nor online booking increased screening uptake by three months (18.8% pre-invitation leaflet vs. 19.2% control and 17.8% online booking vs. 17.2% control). Uptake was higher amongst human papillomavirus vaccinees at three months (OR 2.07, 95% CI 1.69-2.53, p < 0.001). Phase 2 randomized 10,126 non-attenders, with 32-34 clusters for each intervention and 100 clusters as controls. Sending self-sample kits increased uptake at 12 months (OR 1.51, 95% CI 1.20-1.91, p = 0.001), as did timed appointments (OR 1.41, 95% CI 1.14-1.74, p = 0.001). The offer of a nurse navigator, a self-sample kits on request, and choice between timed appointments and nurse navigator were ineffective. Conclusions Amongst non-attenders, self-sample kits sent and timed appointments achieved an uplift in screening over the short term; longer term impact is less certain. Prior human papillomavirus vaccination was associated with increased screening uptake.

Indexed as

Early Detection of CancerPatient ParticipationAdultEnglandFemaleHumansInfantMiddle AgedPapillomaviridaePapillomavirus InfectionsPapillomavirus VaccinesState MedicineTreatment OutcomeUterine Cervical NeoplasmsVaginal SmearsYoung AdultPapillomavirus VaccinesCervical screeninguptakeyoung women

Identifiers

PMID28530513
PMCPMC5956569

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.